Integra LifeSciences | IART - 销售和管理费用

金融业

USD

USD 3.6B

现金及等价物

USD 235.05M

USD 193.45M

USD 1.16B

USD 455.98M

USD 2.01B

USD 66.01M

USD 104.21M

4.4K

EPS每股收益

USD 0.83

股本和储备

USD 1.04B

USD 217.1M

债务利息支出

USD 23.67M

USD 4.98M

USD 1.86B

USD 722.8M

USD -1.7M

USD 368.92M

USD 66.01M

普通股股本

USD 77.89M

6.59

USD -6.82M

USD 434.9M

销售和管理费用

USD 156.45M

USD 492.74M

贸易债权人

USD 95.73M

应收帐款人

USD 278.85M

	销售和管理费用	更改		日
Abbott	USD 3.13B		125M	2025-12
AtriCure	USD 78.34M		109K	2025-12
Baxter International	USD 761M		53M	2025-12
Becton, Dickinson and Co.	USD 1.39B		27M	2025-12
Boston Scientific	USD 1.83B		93M	2025-12
CONMED	USD 166.76M		26.42M	2025-12
Cooper Companies	USD 373.1M		46.1M	2025-12
Dexcom	USD 299.9M		31.5M	2025-12
Edwards Lifesciences	USD 602.9M		88.3M	2025-12
Globus Medical	USD 318.48M		4.88M	2025-12
HeartBeam	USD 2.01M		46K	2025-03
Hologic	USD 2.5B		2.24B	2025-12
Insulet	USD 331.4M		16.2M	2025-12
Integra LifeSciences	USD 156.45M		12.6M	2025-12
Intuitive Surgical	USD 687.1M		113.8M	2025-12
J&J	USD 6.75B		831M	2025-12
Medtronic	2.97B		159M	2025-09
Merit Medical Systems	USD 114.83M		7.45M	2025-12
Orthofix International	USD 130.35M		11.31M	2025-12
Smith & Nephew	USD 1.42B		65M	2025-12
Stryker	USD 2.14B		150M	2025-12
Tandem Diabetes Care	USD 99.86M		5.34M	2025-12
Teleflex	USD 222.37M		59.4M	2025-12
Zimmer Biomet Holdings	USD 855.7M		44.3M	2025-12